Filing Fee Exhibit

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-1

Clearmind Medicine Inc.

Table 1: Newly Registered and Carry Forward Securities


Line Item Type	Security Type	Security Class Title	Notes	Fee Calculation Rule	Amount Registered	Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price		Fee Rate	Amount of Registration Fee

Newly Registered Securities
Fees to be Paid	Equity	Common shares, no par value per share	(1)	Other	17,016,694	$	1.01	$	17,186,860.94	0.0001531	$	2,631.31

Total Offering Amounts:								$	17,186,860.94			2,631.31
Total Fees Previously Paid:												0.00
Total Fee Offsets:												0.00
Net Fee Due:											$	2,631.31

__________________________________________
Offering Note(s)

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional common shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.

Consists of an aggregate of 17,016,694 of the Registrant’s common shares, no par value per share, consisting of (i) 16,970,241 common shares issued or issuable upon the conversion of convertible promissory notes and (ii) 46,453 common shares that were issued to certain selling shareholders as equity award grants outside of the Registrant’s Omnibus Stock Award Plan. All 17,016,694 common shares are to be offered for resale by the selling shareholders named in the prospectus contained in this Registration Statement on Form F-1.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high ($1.03) and low sale ($0.99) prices of the Registrant’s common shares on the Nasdaq Capital Market on September 16, 2025.

The Registrant will not receive any proceeds from the sale of its common shares by the selling shareholders.